Healthtech Series B Investors & VC Firms
1216 firms in this list, with a median first check of $750K. 285 of them lead rounds. Generated from verified public data and updated continuously.
Verve Ventures
ZugSeed–Series B$1.1M – $2.2M
9 people
SJF Ventures
DurhamSeries A–Late Stage$1M – $10M
13 people
Claritas Capital
NashvilleSeed–Late Stage$2M – $5M
19 people
Jerusalem Venture Partners (JVP)
JerusalemSeed–Late Stage$1.5M – $43M
37 people
Alteria Capital
MumbaiSeed–Late Stage$100K – $15M
28 people
HealthCap
StockholmSeed–Growth
30 people
Visible Ventures
HinghamPre-Seed–Series B$1M
27 people
Vocap Partners
Vero BeachSeries A–Growth$5M – $15M
32 people
Z47 (formerly Matrix Partners India)
BengaluruSeed–Series B$2M – $10M
14 people
DOMiNO Ventures
AmsterdamSeed–Series B$220K – $1.1M
30 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
14 people
Safar Partners
CambridgePre-Seed–Late Stage
20 people
PMV
BrusselsPre-Seed–Late Stage
1 person
UOB Venture Management
SingaporeSeed–Growth$10M – $50M
32 people
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
Mobile Internet Capital, Inc.
TokyoPre-Seed–Late Stage$1M – $85M
6 people
SemperVirens Venture Capital
San MateoPre-Seed–Growth
18 people
aMoon
Ra'ananaSeed–Late Stage
25 people
Noro-Moseley Partners
AtlantaSeries A–Late Stage$5M – $20M
10 people
Seneca Partners
HaydockSeed–Growth
13 people
Impact Fund Denmark
CopenhagenSeed–Late Stage$2.2M – $70.2M
36 people
Echo Health Ventures
DurhamSeed–Growth
28 people
Rho Ventures
New YorkPre-Seed–Late Stage$2M – $15M
10 people
2050
ParisSeed–Late Stage
29 people
Related lists
Series B Investors & VC Firms (4094)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Series B Investors & VC Firms in United States (1625)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)SaaS Series B Investors & VC Firms (1317)Series B Investors & VC Firms in Global (1265)Enterprise Software Series B Investors & VC Firms (1242)
Data sourced from public filings and firms' own websites — see our methodology.



































































